OTCM
TSNDF
Market cap193mUSD
Jul 09, Last price
0.57USD
1D
-6.39%
1Q
-8.64%
IPO
-63.51%
Name
Terrascend Corp
Chart & Performance
P/E
—
P/S
0.74
EPS
—
Div Yield, %
—
Shrs. gr., 5y
14.99%
Rev. gr., 5y
5.61%
Revenues
261m
-15.04%
Net income
-86m
L+7.47%
CFO
22m
-43.27%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
TerrAscend Corp. is an enterprise actively involved in the cultivation, processing, and distribution of cannabis for both medicinal and adult recreational use across Canada and the United States. Beyond its core cannabis activities, the company also manufactures artisanal edibles infused with cannabis and supplies hemp-derived wellness products to various retail outlets. TerrAscend maintains a substantial retail presence, operating dispensaries under multiple banners, such as The Apothecarium locations in California and Pennsylvania. As of July 26, 2022, its retail footprint encompassed a total of 27 dispensaries, including three Cookies-branded stores in Michigan and one in Toronto. The company further strengthens its market position through a diverse portfolio of synergistic brands, which includes Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. Established in 2017, TerrAscend Corp. is headquartered in Mississauga, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||